Viewpoints

Fighting Through This Slow Season of Change

March 02, 2021

Bio/pharma works hard today to change the calendar to tomorrow.

Meeting CGT Demand

March 02, 2021

More work is needed to ensure the rising demand for cell and gene therapy manufacturing capacity and required skilled workforce can be met in Europe.

Continued Innovation is Key for COVID-19 Recovery

February 02, 2021

More work is needed to educate businesses on the value of innovation and the availability of funding.

In Short Supply

February 02, 2021

COVID-19 vaccine supplies are breaking news headlines, in both ‘good’ and ‘not so good’ ways.

How Pharmaceutical Innovation is Saving the World

February 02, 2021

Viewpoint

Viewpoint: Mike Hennessy, Sr., founder and chairman of MJH Life Sciences, commends the leadership of the pharmaceutical industry in combatting the COVID-19 pandemic.

A Hopeful but Dangerous Phase

February 02, 2021

A complicated vaccination rollout and mixed messages may derail the pandemic endgame.

A Bright Outlook

January 02, 2021

The outlook for the European pharma industry is appearing to be favourable overall.

Calling for Clarity

November 02, 2020

Industry wants clarification on compliance following the end of the Brexit transition period.

Pandemic-fighting Drugs in Shortage, Again

November 02, 2020

Resolving drug shortages starts with identifying the source of the problem.

Viewpoint: Precompetitive Collaboration Drives Pharma Industry Innovation

October 15, 2020

The IQ Consortium marks a decade of impactful innovation of collaboration through a network of pharmaceutical companies driving change for the bio/pharmaceutical industry.